Prostate MRI: Who, when, and how? Report from a UK consensus meeting. Clin Radiol. 2013;68:1016–23.A. P. S. Kirkham, P. Haslam, J. Y. Keanie et al., "Prostate MRI: Who, when, and how? Report from a UK consensus meeting," Clinical Radiology, vol. 68, no. 10, pp. 1016...
It does not address detection of recurrence, progression during active surveillance and evaluation of other parts of the body. PI-RADS v2 improves and standardises communication between radiologists and urologists to detect or exclude the presence of significant prostate cancer with a high likelihood....
None of the above is likely to lead to lasting improvement unless you work at consistently feeling emotionally balanced. If you're not sure where to begin with addressing your emotional stressors, please have a look at the mind-body exercises found here: ...
We explore techniques in positron emission tomography (PET), magnetic resonance imaging (MRI), second generation harmonic Imaging (SGHI), ultrasound (US), radiomics, and artificial intelligence (AI). A new diagnostic imaging tool in PET/computed tomography (CT) is the use of radiolabeled ...
“The MRI/ultrasound-guided transperineal approach allows easy access to anterior prostate tumors,” says Marc A. Bjurlin, DO, MSc, FACOS, in this video. In this interview, Marc A. Bjurlin, DO, MSc, FACOS, describes the ways in which MRI-guided biopsies can be performed. Bjurlin is...
A benign tumor is either surgically removed, or it may be left in place and simply observed to see what it does. The decision to remove or observe depends on the tumor's size, type and location. Next, we'll look at some of the causes of cancer. Causes of Cancer Cancer is caused ...
Figure 3: Table depicting the proposed simplified PI-RADS for bp-MRI adapted from7. How does a PI-RADS score relate to a Gleason score? The PI-RADS score is determined by a radiologist based on prostate MRI scans, whereas the Gleason score is set by the pathologist based on the results...
enlarged prostate, bladder obstruction, or other urination problems; gout; lupus; diabetes; an allergy tosulfa drugs; kidney disease; or cirrhosis or other liver disease. Tell your doctor if you have an MRI (magnetic resonance imaging) or any type of scan using a radioactive dye that is inje...
“would be useful in assessing the treatment effect of products in patients with nonmetastatic castration resistant prostate cancer”. MFS does not, however, account for patients who experience a rise in PSA, which often occurs before metastatic disease and is indicative of inadequate disease control...
How can mpMRI help surgical planning in high risk prostate cancer?doi:10.1038/s41391-019-0192-8Lorenzo BianchiRiccardo SchiavinaEugenio BrunocillaProstate Cancer and Prostatic Diseases